Be the cure
Be the cure
Be the
Change a life
Change a life
Change a
Join our team
Join our team
Join our

The expertise to create cures and life-changing treatments

Assembly Bio is passionately applying scientific ingenuity and a deep knowledge of virology to find a cure for hepatitis B (HBV) infection, one of the world’s most prevalent and devastating infectious diseases. Be a part of our ambitious and caring life’s work. Together, we have the potential to change lives.

In the News
July 20, 2021
Nobel Laureate Dr. Michael Houghton Appointed to Assembly Biosciences Board of Directors
July 02, 2021
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 23, 2021
Assembly Biosciences Presents Data from HBV Core Inhibitor Programs at the International Liver Congress™ EASL 2021
    Be the cure

    “It’s time to end the deadly Hepatitis B virus that has killed more than 800,000 people a year, including my own family members. I’m encouraged by the efforts of Assembly Bio to develop better treatments that could lead to a cure.”

    — Alan Wang, Emmy award-winning television news anchor.
    Infected at birth with chronic Hepatitis B.

    Change a life

    “As a resident in Anesthesiology and Intensive Care, I’ve seen patients die of the consequences of hepatitis B, and I can see that it has a devasting impact on people in every country around the world. Now is the time to cure hepatitis B and save over 800,000 unnecessary deaths every year. I am grateful for the support and partnership of Assembly Bio in our shared goal of eradicating hepatitis B once and for all.”

    — Dr Hélène Drouin, Resident in Anesthesiology and Intensive Care,
    future Mount Everest climber